Advanced small-cell colon carcinoma: a case report

por Iwase, Toshiaki, Masuda, Yoshinori, Suzuki, Takayuki, Takahashi, Osamu, Miyazaki, Masaru
Publicado 2013

The Relationship Between Skeletal-Related Events and Bone Scan Index for the Treatment of Bone Metastasis With Breast Cancer Patients

por Iwase, Toshiaki, Yamamoto, Naohito, Ichihara, Hironori, Togawa, Takashi, Nagashima, Takeshi, Miyazaki, Masaru
Publicado 2014

Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling

por Dong, Wenli, Fujii, Takeo, Ning, Jing, Iwase, Toshiaki, Qin, Jing, Ueno, Naoto T, Shen, Yu
Publicado 2023

Targeting Signaling Pathways in Inflammatory Breast Cancer

por Wang, Xiaoping, Semba, Takashi, Phi, Lan Thi Hanh, Chainitikun, Sudpreeda, Iwase, Toshiaki, Lim, Bora, Ueno, Naoto T.
Publicado 2020

Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients

por Iwase, Toshiaki, Sangai, Takafumi, Nagashima, Takeshi, Sakakibara, Masahiro, Sakakibara, Junta, Hayama, Shouko, Ishigami, Emi, Masuda, Takahito, Miyazaki, Masaru
Publicado 2015

Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer

por Iwase, Toshiaki, Shrimanker, Tushaar Vishal, Rodriguez-Bautista, Ruben, Sahin, Onur, James, Anjali, Wu, Jimin, Shen, Yu, Ueno, Naoto T.
Publicado 2021

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines

por Xie, Xuemei, Lee, Jangsoon, Fuson, Jon A., Liu, Huey, Iwase, Toshiaki, Yun, Kyuson, Margain, Cori, Tripathy, Debu, Ueno, Naoto T.
Publicado 2023

Inflammatory breast cancer biomarker identification by simultaneous TGIRT-seq profiling of coding and non-coding RNAs in tumors and blood

por Wylie, Dennis, Wang, Xiaoping, Yao, Jun, Xu, Hengyi, Ferrick-Kiddie, Elizabeth A., Iwase, Toshiaki, Krishnamurthy, Savitri, Ueno, Naoto T., Lambowitz, Alan M.
Publicado 2023

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

por Chainitikun, Sudpreeda, Espinosa Fernandez, Jose Rodrigo, Long, James P., Iwase, Toshiaki, Kida, Kumiko, Wang, Xiaoping, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.
Publicado 2021

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening

por Lee, Jangsoon, Liu, Huey, Pearson, Troy, Iwase, Toshiaki, Fuson, Jon, Lalani, Alshad S., Eli, Lisa D., Diala, Irmina, Tripathy, Debu, Lim, Bora, Ueno, Naoto T.
Publicado 2021

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer

por Kida, Kumiko, Hess, Kenneth R., Lim, Bora, Iwase, Toshiaki, Chainitikun, Sudpreeda, Valero, Vicente, Lucci, Anthony, Le-Petross, Huong Carisa, Woodward, Wendy A., Krishnamurthy, Savitri, Hortobagyi, Gabriel N., Tripathy, Debu, Ueno, Naoto T.
Publicado 2020

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy

por Iwase, Toshiaki, Parikh, Aaroh, Dibaj, Seyedeh S., Shen, Yu, Shrimanker, Tushaar Vishal, Chainitikun, Sudpreeda, Kida, Kumiko, Sapon, Maryanne E., Sahin, Onur, James, Anjali, Medrano, Andrea Yizel Delgado, Klopp, Ann H., Ueno, Naoto T.
Publicado 2021

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer

por Iwase, Toshiaki, Blenman, Kim R. M., Li, Xiaotong, Reisenbichler, Emily, Seitz, Robert, Hout, David, Nielsen, Tyler J., Schweitzer, Brock L., Bailey, Daniel B., Shen, Yichao, Zhang, Xiang, Pusztai, Lajos, Ueno, Naoto T.
Publicado 2021

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

por Iwase, Toshiaki, Harano, Kenichi, Masuda, Hiroko, Kida, Kumiko, Hess, Kenneth R., Wang, Ying, Dirix, Luc, Van Laere, Steven J., Lucci, Anthony, Krishnamurthy, Savitri, Woodward, Wendy A., Layman, Rachel M., Bertucci, François, Ueno, Naoto T.
Publicado 2020

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

por Ueno, Naoto T., Tahara, Rie K., Fujii, Takeo, Reuben, James M., Gao, Hui, Saigal, Babita, Lucci, Anthony, Iwase, Toshiaki, Ibrahim, Nuhad K., Damodaran, Senthil, Shen, Yu, Liu, Diane D., Hortobagyi, Gabriel N., Tripathy, Debu, Lim, Bora, Chasen, Beth A.
Publicado 2019

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

por Lim, Bora, Murthy, Rashmi K., Lee, Jangsoon, Jackson, Summer A., Iwase, Toshiaki, Davis, Darren W., Willey, Jie S., Wu, Jimin, Shen, Yu, Tripathy, Debu, Alvarez, Ricardo, Ibrahim, Nuhad K., Brewster, Abenaa M., Barcenas, Carlos H., Brown, Powel H., Giordano, Sharon H., Moulder, Stacy L., Booser, Daniel J., Moscow, Jeffrey A., Piekarz, Richard, Valero, Vicente, Ueno, Naoto T.
Publicado 2019

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer

por Wang, Xiaoping, Semba, Takashi, Manyam, Ganiraju C., Wang, Jing, Shao, Shan, Bertucci, Francois, Finetti, Pascal, Krishnamurthy, Savitri, Phi, Lan Thi Hanh, Pearson, Troy, Van Laere, Steven J., Burks, Jared K., Cohen, Evan N., Reuben, James M., Yang, Fei, Min, Hu, Navin, Nicholas, Trinh, Van Ngu, Iwase, Toshiaki, Batra, Harsh, Shen, Yichao, Zhang, Xiang, Tripathy, Debu, Ueno, Naoto T.
Publicado 2022